Renal insufficiency, bleeding and prescription of discharge medication in patients undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry.
Academic Article
Overview
Research
Identity
Additional Document Info
View All
Overview
abstract
To establish the relationship between renal insufficiency, bleeding and prescription of cardiovascular medication.This was a prospective, multi-center, cohort study of consecutive patients undergoing PCI during three NHLBI Dynamic Registry recruitment waves. Major and minor bleeding, access site bleeding and rates of prescription of cardiovascular medication at discharge were determined based on estimated glomerular filtration rate (eGFR). Renal insufficiency was an independent predictor of major adverse cardiovascular events (MACE). Bleeding events and access site bleeding requiring transfusion were significantly associated with degrees of renal insufficiency (p<0.001). There was an incremental decline in prescription of cardiovascular medication at discharge proportionate to the degree of renal impairment (aspirin, thienopyridine, statin, coumadin (overall p<0.001), beta blocker (overall p=0.003), ACE inhibitor (overall p=0.02). Bleeders were less likely to be discharged on a thienopyridine (95.4% versus 89.9% for bleeding, p<0.001 and 95.3% versus 87.9% for access site bleeding, p=0.005), but not aspirin (96.3% versus 96.2%, p=0.97 and 96.3% versus 93.6%, p=0.29 respectively). Failure to prescribe anti-platelet therapy at discharge was strongly associated with increased MACE at one year.Renal insufficiency is associated with bleeding in patients undergoing PCI. Patients with renal insufficiency are less likely to receive recommended discharge pharmacotherapy.Copyright © 2016 Elsevier Inc. All rights reserved.
publication date
published in
Research
keywords
Aged
Blood Transfusion
Canada
Cardiovascular Agents
Czech Republic
Drug Prescriptions
Female
Glomerular Filtration Rate
Hemorrhage
Humans
Kidney
Male
Middle Aged
Myocardial Infarction
National Heart, Lung, and Blood Institute (U.S.)
Patient Discharge
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Prospective Studies
Recurrence
Registries
Renal Dialysis
Renal Insufficiency
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
United States
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
number